SanBio Company Limited Logo

SanBio Company Limited

Develops regenerative cell-based therapies for neurological disorders.

4592 | T

Overview

Corporate Details

ISIN(s):
JP3336750009
LEI:
Country:
Japan
Address:
中央区明石町8番1号

Description

SanBio Company Limited is a regenerative medicine company focused on the research, development, and commercialization of cell-based therapies for neurological disorders. The company develops treatments intended to restore lost nerve function in patients with central nervous system conditions. Its lead product, AKUUGO® (development code: SB623), is a proprietary, allogeneic cell therapy derived from bone marrow stromal cells. It is administered via intracranial implantation and is developed for treating chronic motor deficits resulting from traumatic brain injury and ischemic stroke.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-07 01:00
訂正臨時報告書
Japanese 31.2 KB
2025-09-12 08:31
確認書
Japanese 7.9 KB
2025-09-12 08:31
半期報告書-第13期(2025/02/01-2026/01/31)
Japanese 230.6 KB
2025-06-13 08:45
臨時報告書
Japanese 19.2 KB
2025-04-24 08:31
臨時報告書
Japanese 23.7 KB
2025-04-23 08:31
確認書
Japanese 8.0 KB
2025-04-23 08:31
内部統制報告書-第12期(2024/02/01-2025/01/31)
Japanese 21.6 KB
2025-04-23 08:30
有価証券報告書-第12期(2024/02/01-2025/01/31)
Japanese 1.3 MB
2025-03-17 07:30
臨時報告書
Japanese 21.2 KB
2025-02-14 07:30
有価証券届出書(参照方式)
Japanese 168.5 KB
2024-12-25 07:30
臨時報告書
Japanese 19.3 KB
2024-12-02 07:30
有価証券届出書(参照方式)
Japanese 112.5 KB
2024-09-17 08:02
臨時報告書
Japanese 19.0 KB
2024-09-17 08:01
確認書
Japanese 7.9 KB
2024-09-17 08:01
半期報告書-第12期(2024/02/01-2024/07/31)
Japanese 181.0 KB

Automate Your Workflow. Get a real-time feed of all SanBio Company Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SanBio Company Limited

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SanBio Company Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Genenta Science S.p.A. Logo
Clinical-stage developer of hematopoietic stem cell gene therapies for immuno-oncology.
United States of America
GNTA
GeneOne Life Science, Inc. Logo
Biopharmaceutical R&D company specializing in nucleic acid-based biomedicines.
South Korea
011000
Geneuro Logo
Develops therapies for neurological and autoimmune diseases by targeting HERVs.
Switzerland
GEM
GENFIT Logo
Develops therapies and diagnostics for patients with rare and severe liver diseases.
France
GNFT
GENFLOW BIOSCIENCES PLC Logo
A biotechnology company developing gene therapies that target the aging process.
United Kingdom
GENF
GENINCODE PLC Logo
Specializes in genetic risk assessment and prediction of cardiovascular disease.
United Kingdom
GENI
GENINUS Inc. Logo
A biotech company offering genomic analysis for precision medicine and drug development.
South Korea
389030
Genomed Spolka Akcyjna Logo
Biotechnology firm for genetic research and molecular diagnostics using NGS technology.
Poland
GEN
A molecular diagnostics company developing tests for the early detection of cancer.
South Korea
228760
Genomic Vision Logo
Provides DNA analysis and quality control for bioproduction and gene therapy.
France
GV

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.